Search Results - "Pietilä‐Effati, Päivi"

Long‐term effectiveness of enzyme replacement therapy in Fabry disease with the p.Arg227Ter variant: Fabry disease in Ostrobothnia (FAST) study by Pietilä‐Effati, Päivi, Saarinen, Jukka T., Löyttyniemi, Eliisa, Saarenhovi, Maria, Autio, Reijo, Kantola, Ilkka

“…Fabry disease (FD) is an X chromosome‐linked, life‐threatening lysosomal disease caused by one of more than 1000 currently known variants in the…”
Get full text

Sudden death in cardiac sarcoidosis: an analysis of nationwide clinical and cause-of-death registries by Ekström, Kaj, Lehtonen, Jukka, Nordenswan, Hanna-Kaisa, Mäyränpää, Mikko I, Räisänen-Sokolowski, Anne, Kandolin, Riina, Simonen, Piia, Pietilä-Effati, Päivi, Alatalo, Aleksi, Utriainen, Seppo, Rissanen, Tuomas T, Haataja, Petri, Kokkonen, Jorma, Vihinen, Tapani, Miettinen, Heikki, Kaikkonen, Kari, Kerola, Tuomas, Kupari, Markku

“…Abstract Aims The present study was done to assess the role of sudden cardiac death (SCD) among the presenting manifestations of and fatalities from cardiac…”
Get full text

Manifestations and Outcome of Cardiac Sarcoidosis and Idiopathic Giant Cell Myocarditis by 25-Year Nationwide Cohorts by Nordenswan, Hanna-Kaisa, Lehtonen, Jukka, Ekström, Kaj, Räisänen-Sokolowski, Anne, Mäyränpää, Mikko I, Vihinen, Tapani, Miettinen, Heikki, Kaikkonen, Kari, Haataja, Petri, Kerola, Tuomas, Rissanen, Tuomas T, Kokkonen, Jorma, Alatalo, Aleksi, Pietilä-Effati, Päivi, Utriainen, Seppo, Kupari, Markku

“…Background Cardiac sarcoidosis (CS) and giant cell myocarditis (GCM) share many histopathologic and clinical features. Whether they are parts of a one-disease…”
Get full text

Pulmonary manifestations and the effectiveness of enzyme replacement therapy in Fabry Disease with the p. Arg227Ter (p.R227) mutation by Pietilä‐Effati, Päivi, Söderström, Johan, Saarinen, Jukka T., Löyttyniemi, Eliisa, Kantola, Ilkka

“…Background Fabry disease (FD) is caused by a defect in α‐galactosidase A gene (GLA) which leads to a progressive accumulation of neutral shingolipids, mainly…”
Get full text

Renal sympathetic denervation in treating drug-resistant hypertension in a patient on hemodialysis by Pietilä-Effati, Päivi M, Salmela, Anna K, Niemi, Risto T, Ylitalo, Antti S, Koistinen, M Juhani

“…A 26-year-old man had an end-stage renal disease because of a neurogenic urinary bladder with a vesicourinary reflux. The first kidney transplant was lost in…”
Get full text

Intravascular Renal Denervation in Renal Dialysis Patients with Uncontrolled Hypertension: A Case Series of Four Patients by Pietilä-Effati, Päivi M, Salmela, Anna K, Koistinen, M Juhani

“…BACKGROUND Hypertension is a common complication of renal dialysis and is inadequately controlled in approximately one-third of patients. Intravascular renal…”
Get full text

Natural course of Fabry disease with the p. Arg227Ter (p.R227) mutation in Finland: Fast study by Pietilä‐Effati, Päivi, Saarinen, Jukka T., Löyttyniemi, Eliisa, Autio, Reijo, Saarenhovi, Maria, Haanpää, Maria K., Kantola, Ilkka

“…Background Fabry disease is caused by a deficient or an absent alfa‐galactosidase A activity and is an X‐linked disorder that results in organ damage and a…”
Get full text

Cardiac Sarcoidosis: Epidemiology, Characteristics, and Outcome Over 25 Years in a Nationwide Study by Kandolin, Riina, Lehtonen, Jukka, Airaksinen, Juhani, Vihinen, Tapani, Miettinen, Heikki, Ylitalo, Kari, Kaikkonen, Kari, Tuohinen, Suvi, Haataja, Petri, Kerola, Tuomas, Kokkonen, Jorma, Pelkonen, Markus, Pietilä-Effati, Päivi, Utrianen, Seppo, Kupari, Markku

“…BACKGROUND—This study was designed to assess the epidemiology, characteristics, and outcome of cardiac sarcoidosis (CS) in Finland. METHODS AND RESULTS—We…”
Get full text

Cardiac Involvement in Fabry Disease: JACC Review Topic of the Week by Pieroni, Maurizio, Moon, James C, Arbustini, Eloisa, Barriales-Villa, Roberto, Camporeale, Antonia, Vujkovac, Andreja Cokan, Elliott, Perry M, Hagege, Albert, Kuusisto, Johanna, Linhart, Aleš, Nordbeck, Peter, Olivotto, Iacopo, Pietilä-Effati, Päivi, Namdar, Mehdi

“…Fabry disease (FD) is a rare X-linked inherited lysosomal storage disorder caused by deficient α-galactosidase A activity that leads to an accumulation of…”
Get full text

Incidence of Sudden Cardiac Death and Life-Threatening Arrhythmias in Clinically Manifest Cardiac Sarcoidosis With and Without Current Indications for an Implantable Cardioverter Defibrillator by Nordenswan, Hanna-Kaisa, Pöyhönen, Pauli, Lehtonen, Jukka, Ekström, Kaj, Uusitalo, Valtteri, Niemelä, Meri, Vihinen, Tapani, Kaikkonen, Kari, Haataja, Petri, Kerola, Tuomas, Rissanen, Tuomas T., Alatalo, Aleksi, Pietilä-Effati, Päivi, Kupari, Markku

“…Cardiac sarcoidosis (CS) predisposes to sudden cardiac death (SCD). Guidelines for implantable cardioverter defibrillators (ICDs) in CS have been issued by the…”
Get full text

End-Stage Heart Failure in Cardiac Sarcoidosis by Velikanova, Diana, Pöyhönen, Pauli, Lehtonen, Jukka, Simonen, Piia, Uusitalo, Valtteri, Vihinen, Tapani, Kaikkonen, Kari, Haataja, Petri, Kerola, Tuomas, Rissanen, Tuomas T, Vepsäläinen, Ville, Alatalo, Aleksi, Pietilä-Effati, Päivi, Kupari, Markku

Get full text

Renal denervation in patients who do not respond to cardiac resynchronization therapy by Pietilä-Effati, Päivi, Höglund, Mathias, Käräjämäki, Aki, Höglund, Filip, Nabb, Anne-Maria, Matila, Eija, Koistinen, M Juhani

“…Cardiac resynchronization therapy (CRT) reduces the morbidity and mortality in advanced heart failure (HF) in about two-thirds of the patients. Approximately…”
Get more information

30-Year Trends in the Incidence, Characteristics, and Outcome of Cardiac Sarcoidosis in a Nationwide Cohort by Pöyhönen, Pauli, Lehtonen, Jukka, Velikanova, Diana, Simonen, Piia, Uusitalo, Valtteri, Mälkönen, Henriikka, Nordenswan, Hanna-Kaisa, Vihinen, Tapani, Kaikkonen, Kari, Haataja, Petri, Kerola, Tuomas, Rissanen, Tuomas T., Vepsäläinen, Ville, Alatalo, Aleksi, Pietilä-Effati, Päivi, Kupari, Markku

“…Cardiac sarcoidosis (CS) is a rare but potentially fatal inflammatory cardiomyopathy. The authors studied temporal changes in the incidence, characteristics,…”
Get full text

Outcome of Cardiac Sarcoidosis Presenting With High-Grade Atrioventricular Block by Nordenswan, Hanna-Kaisa, Lehtonen, Jukka, Ekström, Kaj, Kandolin, Riina, Simonen, Piia, Mäyränpää, Mikko, Vihinen, Tapani, Miettinen, Heikki, Kaikkonen, Kari, Haataja, Petri, Kerola, Tuomas, Rissanen, Tuomas T, Kokkonen, Jorma, Alatalo, Aleksi, Pietilä-Effati, Päivi, Utriainen, Seppo, Kupari, Markku

“…BACKGROUND:Symptomatic high-grade atrioventricular block (AVB) is the most common and often the only presenting manifestation (lone AVB) of cardiac…”
Get full text

Incidence of Sudden Cardiac Death and Life-Threatening Arrhythmias in Clinically Manifest Cardiac Sarcoidosis With and Without Current Indications for an Implantable Cardioverter Defibrillator by Nordenswan, Hanna-Kaisa, Pöyhönen, Pauli, Lehtonen, Jukka, Ekström, Kaj, Uusitalo, Valtteri, Niemelä, Meri, Vihinen, Tapani, Kaikkonen, Kari, Haataja, Petri, Kerola, Tuomas, Rissanen, Tuomas T., Alatalo, Aleksi, Pietilä-Effati, Päivi, Kupari, Markku

Get full text

The natural course of Fabry disease in a Finnish R227X cohort by Pietilä-Effati, Päivi, Saarinen, Jukka T., Löyttyniemi, Eliisa, Autio, Reijo, Saarenhovi, Maria, Kantola, Ilkka

“…Fabry disease caused by a genetic deficiency of alfagalactosidase activity results in accumulation of glycosphingolipids especially in vascular endothelium…”
Get full text

Cardiac Involvement in Fabry Disease by Pieroni, Maurizio, Moon, James C., Arbustini, Eloisa, Barriales-Villa, Roberto, Camporeale, Antonia, Vujkovac, Andreja Cokan, Elliott, Perry M., Hagege, Albert, Kuusisto, Johanna, Linhart, Aleš, Nordbeck, Peter, Olivotto, Iacopo, Pietilä-Effati, Päivi, Namdar, Mehdi

Get full text

Enzyme replacement therapy together with renin-angiotensin system inhibition seems to prevent kidney function decrease in most Finnish Fabry patients treated either for 5 or 10 years by Kantola, Ilkka, Annala, Antti-Pekka, Ekstrand, Agneta, Heliö, Tiina, Hietaharju, Aki, Kananen, Kristiina, Kantola, Taru, Karhu, Anne, Kokkonen, Jorma, Kuusisto, Johanna, Pietila-Effati, Päivi, Rainto, Miia, Saarinen, Jukka T., Sandini, Lorenzo, Savolainen, Markku, Taurio, Jyrki, Tienari, Pentti, Ukkola, Olavi, Valtola, Kati, Walls, Susanne, Yliaska, Iina

“…Enzyme replacement therapy (ERT) has stabilized renal function but its effect on proteinuria is inconsistent. Also nephroprotective…”
Get full text

Long-term effectiveness of enzyme replacement therapy in Fabry disease with the p. Arg227Ter (R227) mutation by Effati, Paivi Pietila, Saarinen, Jukka T., Löyttyniemi, Eliisa, Saarenhovi, Maria, Autio, Reijo, Kantola, Ilkka

Get full text

Aging Fabry disease patients by Kantola, Ilkka, Hietaharju, Aki, Kuusisto, Johanna, Kylmälä, Minna M., Effati, Paivi Pietila, Taurio, Jyrki, Valtola, Kati, Yliaska, Iina, Saarinen, Jukka

Get full text